title: Treatment of segmental bone defects in rats by the stimulation of bone marrow osteo-progenitor cells with prostaglandin E2.
abstract: An alternative to bone grafting is engineered osteo-conductive material that carries osteo-progenitor cells with osteo-stimulant factors impregnated on a malleable osteo-conductive material. We used bone marrow stem cells as the source of osteo-progenitor cells and stimulated them with prostaglandin E2 using demineralised bone matrix as a carrier. We treated 35 skeletally mature male Wistar albino rats with segmentary radial bone defects using five different treatment groups. Group I received no treatment; the remaining four groups all received a mixture of bone marrow and demineralised bone matrix. In group III, a copolymer was added. In group IV, prostaglandin E2 and in group V prostaglandin E2 within a copolymer was added to the mixture. Eight weeks after the surgical procedure, the rats were sacrificed. Radiological and histological evaluation of the radial bone showed that while there was no significant healing in groups I, II and III, there was a significant healing response in groups IV and V.
authors.affiliation: Department of Orthopaedics and Traumatology, Faculty of Medicine, Gazi Hospital, Gazi University, Ankara, Turkey. a.muhtar.ozturk@tr.net
authors.forename: A M
authors.initials: AM
authors.lastname: Ozturk
authors.forename: E
authors.initials: E
authors.lastname: Cila
authors.forename: U
authors.initials: U
authors.lastname: Kanatli
authors.forename: I
authors.initials: I
authors.lastname: Isik
authors.forename: A
authors.initials: A
authors.lastname: Senkoylu
authors.forename: D
authors.initials: D
authors.lastname: Uzunok
authors.forename: E
authors.initials: E
authors.lastname: Piskin
mesh_terms: D000818:Animals; D001854:Bone Marrow Cells / Q000187:drug effects*; D001861:Bone Regeneration / Q000187:drug effects; D016025:Bone Transplantation / Q000379:methods; D015232:Dinoprostone / Q000494:pharmacology*; D017102:Fracture Healing / Q000187:drug effects; D006133:Growth Substances / Q000494:pharmacology*; D008297:Male; D023421:Models, Animal; D011885:Radius Fractures / Q000628:therapy*; D051381:Rats; D017208:Rats, Wistar; D013234:Stem Cells / Q000187:drug effects*; D023822:Tissue Engineering / Q000379:methods
chemical_list: D006133:Growth Substances; D015232:Dinoprostone